Bris­tol My­ers launch­es pro­gram to make clin­i­cal tri­als more ac­ces­si­ble for peo­ple with dis­abil­i­ties

About a fourth of US adults live with some type of dis­abil­i­ty, ac­cord­ing to the CDC. On Wednes­day, Bris­tol My­ers Squibb launched a new ini­tia­tive to en­sure those pa­tients get ac­cess to clin­i­cal tri­als.

The phar­ma gi­ant is team­ing up with the non­prof­it Dis­abil­i­ty So­lu­tions to cre­ate the Dis­abil­i­ty Di­ver­si­ty in Clin­i­cal Tri­als (DDiCT) Ini­tia­tive, a pro­gram that’s ini­tial­ly fo­cus­ing on com­ing up with a set of rec­om­men­da­tions for im­prov­ing ac­cess, speed of en­roll­ment and par­tic­i­pa­tion of peo­ple with dis­abil­i­ties in tri­als.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER